Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ansieau

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Immunobiology|July 1, 1995
Gene regulation by NF-M and Myb during differentiation and leukemic transformationE Kowenz-Leutz, S Ansieau, G Twamley, et al.
FEBS Letters|December 12, 1997
Cloning of two novel human importin-alpha subunits and analysis of the expression pattern of the importin-alpha protein familyM Köhler, S Ansieau, S Prehn, et al.
Bulletin Du Cancer|December 23, 2009
[Role of the epithelial-mesenchymal transition during tumor progression]S Ansieau, C Caron de Fromentel, J Bastid, et al.
Journal of Neuroscience Research|July 1, 1989
Complete sequence of a cDNA encoding an active rat choline acetyltransferase: a tool to investigate the plasticity of cholinergic phenotype expressionA Brice, S Berrard, B Raynaud, et al.
Oncogene|June 11, 1999
The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulatorsR Dechend, F Hirano, K Lehmann, et al.
Oncogene|December 21, 1995
The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivoP Dhordain, O Albagli, S Ansieau, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 1997
Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoproteinP Dhordain, O Albagli, R J Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 1996
Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activationS Ansieau, I Scheffrahn, G Mosialos, et al.
Oncogene|June 7, 2011
TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expressionC Ruptier, A De Gaspéris, S Ansieau, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Immunobiology|July 1, 1995
Gene regulation by NF-M and Myb during differentiation and leukemic transformationE Kowenz-Leutz, S Ansieau, G Twamley, et al.
FEBS Letters|December 12, 1997
Cloning of two novel human importin-alpha subunits and analysis of the expression pattern of the importin-alpha protein familyM Köhler, S Ansieau, S Prehn, et al.
Bulletin Du Cancer|December 23, 2009
[Role of the epithelial-mesenchymal transition during tumor progression]S Ansieau, C Caron de Fromentel, J Bastid, et al.
Journal of Neuroscience Research|July 1, 1989
Complete sequence of a cDNA encoding an active rat choline acetyltransferase: a tool to investigate the plasticity of cholinergic phenotype expressionA Brice, S Berrard, B Raynaud, et al.
Oncogene|June 11, 1999
The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulatorsR Dechend, F Hirano, K Lehmann, et al.
Oncogene|December 21, 1995
The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivoP Dhordain, O Albagli, S Ansieau, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 6, 1997
Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoproteinP Dhordain, O Albagli, R J Lin, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 26, 1996
Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activationS Ansieau, I Scheffrahn, G Mosialos, et al.
Oncogene|June 7, 2011
TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expressionC Ruptier, A De Gaspéris, S Ansieau, et al.
Pageof 2